Oligopeptide fragments of the enkephalin molecule interfere with hematopoietic cell colony formation

International Journal of Immunopathology and Pharmacology

Volumn 13, Issue 1, 2000, Pages 13-19

  Breljak, D ^a   Boranic, M ^a   Horvat, S ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b Dept of Organ Chem and Biochem ^*  (Croatia)

Author keywords

Bone marrow cells; CFU GM; Methionine enkephalin; Naloxone; Oligopeptides

Indexed keywords

DIPEPTIDE; METENKEPHALIN; NALOXONE; NEUROPEPTIDE; OPIATE; OPIATE RECEPTOR; TRIPEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; COLONY FORMATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0034068174     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200001300102     Document Type: Article

References (24)

1. Pleuvry B.J. 1991. Opioid receptors and their ligands: natural and unnatural. Br. J. Anaesth. 66:370.
2. Blalock J.E. 1994. The syntax of immune-neuroendocrine communication. Immunol. Today 15:504.
3. Knapp R.J., E. Malatynska, N. Collins, L. Fang, J.Y. Wang, V.J. Hruby, W.R. Roeske and H.I. Yamamura. 1995. Molecular biology and pharmacology of cloned opioid receptors. FASEB J. 9:516.
4. Uhl G.R., S. Childers and G. Pasternak. 1994. An opiate-receptor gene family reunion. Trends Neurosci. 17:89.
5. Ashmun R.A. and A.T. Look. 1990. Metalloprotease activity of CD13 aminopeptidase N on the surface of human myeloid cells. Blood 75:462.
6. Shipp A.M. and A.T. Look. 1993. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key. Blood 82:1052.
7. Kowalski J. 1998. Imunological action of (Met-5)enkephalin fragments. Eur. J. Pharmacol. 347:95.
8. Owen D.L., J.S. Morley, D.M. Ensor and J.B. Miles. 1998. The C-terminal tetrapeptide of beta-endorphin (MPF) enhances lymphocyte proliferative responses. Neuropeptides 32:1317.
9. Sizemore R.C., R.L. Dienglewicz, E. Pecunia and A.A. Gottlieb. 1991. Modulation of concanavalin A-induced, antigen-nonspecific regulatory cell activity by Leu-enkephalin and related peptides. Clin. Immunol. Immunopathol. 60:310.
10. Boranic̀ M., L.J. Krizanac-Bengez, J. Gabrilovac, T. Marotti and D. Breljak. 1997. Enkephalins in hematopoiesis. Biomed. Pharmacother. 51:29.
11. Krizanac-Bengez L.J., M. Boranic, N.G. Testa and T. Marotti. 1992. Effect of enkephalins on bone marrow cells. Biomed. Pharmacother. 46:367.
12. Mansour A., M.T. Hovertsen, L.P. Taylor, S.J. Watson and H. Akil. 1995. The cloned (, ( and ( receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res. 700:89.
13. Karasuyama H. and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
14. Horvat S., J. Horvat, D. Kantoci and L. Varga. 1989. Glicoconjugates of opioid peptides-III+. A novel regioselective synthesis of 6-O-peptidil-D-glycopiranoses using unprotected sugars. Tetrahedron 45:4579.
15. Haberstock H. and T. Marotti. 1995. The relevance of intact enkephalin molecule in predominantly ( opioid receptor mediated superoxide anion release. Neuropeptides 29:357.
16. Laerum O.D., O. Sletvold, R. Bjerknes and W.R. Paukovits. 1987. A synthetic hemoregulatory peptide (HP5b) inhibits human myelopoietic colony formation (CFU-GM) but not leukocyte phagocytosis in vitro. Eur. J. Haematol. 39:259.
17. Laerum O.D., A. Aakvaag, S. Frostad, T. Kalland, P. Langen and H.R. Maurer. 1990. Selectivity of hemoregulatory peptide (HP5b) action in culture. Int. J. Cell Cloning 8:431.
18. Williamson S.A., R.A. Knight, S.L. Lightman and J.R. Hobbs. 1988. Effects of beta endorphin on specific immune responses in man. Immunology 65:47.
19. Marotti T., V. äverko and I. Hröak. 1990. Modulation of superoxide anion release from human polymorphonuclear cells by Met- and Leu-enkephalin. Brain Behav. Immun. 4:13.
20. Langen P., H. Schunck, B. Hunger, M. Schütt and O.D. Laerum. 1992. Adherent-cell dependent stimulation of CFU-GM by nucleobases, nucleosides, their analogues, and the hemoregulatory peptide dimer. Exp. Hematol. 20:196.
21. Bonnet D., F.M. Lemoine, S. Pontvert-Delucq, C. Baillou, A. Najman and M. Guigon. 1993. Direct and reversible inhibitory effect of the tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (Seraspenide) on the growth of human CD34+ subpopulations in response to growth factors. Blood 82:3307.
22. Cashman J.D., A.C. Eaves and C.J. Eaves. 1994. The tetrapeptide AcSDKP specificaly blocks the cycling of primitive normal but not leukemic progenitors in long-term cultures: evidence for an indirect mechanism. Blood 84:1534.
23. Bongiorno L., A. Urbani, M. Marini, E. Gilardi and L. G. Roda. 1992. Hydrolysis and association of leucine enkephalin to lymphonic and erythroleukemic cell lines ñ II. Int. J. Immunopharmac. 14:643.
24. Guigon M. and D. Bonnet. 1995. Inhibitory peptides in hematopoiesis. Exp. Hematol. 23:477.